We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Life Sciences/Conventional and novel stem cell based therapies for androgenic alopecia
PeriodicalsLife Sciences

Conventional and novel stem cell based therapies for androgenic alopecia

Checking your access to this record.

Abstract & Overview

The prevalence of androgenic alopecia (AGA) increases with age and it affects both men and women. Patients diagnosed with AGA may experience decreased quality of life, depression, and feel self-conscious. There are a variety of therapeutic options ranging from prescription drugs to non-prescription medications. Currently, AGA involves an annual global market revenue of US$4 billion and a growth rate of 1.8%, indicating a growing consumer market. Although natural and synthetic ingredients can promote hair growth and, therefore, be useful to treat AGA, some of them have important adverse effects and unknown mechanisms of action that limit their use and benefits. Biologic factors that include signaling from stem cells, dermal papilla cells, and platelet-rich plasma are some of the current therapeutic agents being studied for hair restoration with milder side effects. However, most of the mechanisms exerted by these factors in hair restoration are still being researched. In this review, we analyze the therapeutic agents that have been used for AGA and emphasize the potential of new therapies based on advances in stem cell technologies and regenerative medicine.

Cite this record

Dodanim Talavera‐Adame, Daniella Newman, Nathan Newman (2017). Conventional and novel stem cell based therapies for androgenic alopecia. Stem Cells and Cloning Advances and Applications, Volume 10, 11–19. https://doi.org/10.2147/sccaa.s138150

Copy in another style

Talavera‐Adame, D., Newman, D., & Newman, N. (2017). Conventional and novel stem cell based therapies for androgenic alopecia. Stem Cells and Cloning Advances and Applications, Volume 10, 11–19. https://doi.org/10.2147/sccaa.s138150
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.